and high normal ACR of 1.83 (1.04-3.22) at follow-up. We adjusted for cardiovascular risk factors including ambulatory blood pressure at baseline and change in use of anti-hypertensive medication between baseline and follow-up.
Limitations:
Only middle-aged Caucasians participated. There is no consensus on how to define glomerular hyperfiltration.
Conclusions:
Our findings imply an independent role of prediabetes in development of hyperfiltration and albuminuria. Prediabetes might be a target for early treatment to prevent chronic kidney disease in chronic hyperglycemia.
Diabetes-related kidney disease accounts for almost 50% of patients with end-stage renal disease in the developed world.P 1 P Even with optimal treatment of new-onset diabetes, a large percentage of patients will develop chronic kidney disease (CKD). Prediabetes is approximately twice as common as diabetes, affecting 20-35% of adults, and it progresses to diabetes in 45-50% of individuals after 10 years.P P 2,3 Prediabetes has been associated with CKD in cross-sectional studies, 4, 5 but whether prediabetes predicts CKD in persons who do not develop diabetes is unclear. Longitudinal studies did not find prediabetes to be an independent risk factor for albuminuria or incident CKD, defined as an estimated GFR < 60 ml/min/1.73 m 2 . [6] [7] [8] [9] [10] [11] If prediabetes is a causal factor in the development of kidney disease, this condition would represent a window of opportunity to treat kidney damage at an early and reversible stage.
Recently, we reported that prediabetes, defined as impaired fasting glucose, was associated with an abnormally high GFR, or glomerular hyperfiltration, in a cross-sectional study of the general population. 12 Glomerular hyperfiltration has been established as an early manifestation of diabetic nephropathy and has been shown to predict albuminuria and GFR decline in diabetes. 13, 14 Hyperfiltration is also a possible common causal pathway for other causes of CKD; however, the longitudinal association between prediabetes and hyperfiltration remains to be established. Previous longitudinal studies assessing the association between prediabetes and kidney function used estimated GFR (eGFR) to assess changes in GFR. eGFR has low precision, particularly in the higher range of GFR, 15 and is expected to have low sensitivity for detecting hyperfiltration and GFR changes in the normal range. eGFR is also biased by non-GFR-related factors such as obesity, smoking, hyperglycemia and nontraditional cardiovascular risk factors. [16] [17] [18] We hypothesized that prediabetes is a risk factor for renal hyperfiltration and high normal ACR during an intermediate follow-up time point. To overcome the limitations of using eGFR, we measured GFR (mGFR) by iohexol clearance at baseline in 2007-2009 and at follow-up in 2013-2015 in a general population cohort without self-reported diabetes, cardiovascular disease (CVD) or kidney disease at baseline. To study the independent role of prediabetes, we excluded persons diagnosed with diabetes at baseline and at follow-up.
RESEARCH DESIGN AND METHODS

Study participants
The Renal Iohexol Clearance Survey in Tromsø 6 (RENIS-T6) was conducted from October 2007 to September 2009 as a sub-study of the population-based sixth Tromsø study (Tromsø 6) in the municipality of Tromsø, northern Norway. 19 The RENIS-T6 included a representative sample of 1627 persons aged 50-62 years from the general population without self-reported kidney disease, myocardial infarction, stroke or diabetes. A description of the study participants and enrollment in the RENIS-T6 is shown in Figure 1 and has been previously published in detail. 19 The RENIS Follow-Up Study (RENIS-FU) was conducted from September 2013 to January 2015. Seven persons had a possible adverse reaction to iohexol in the RENIS-T6, and 23
persons died during the follow-up period. The remaining 1597 participants were invited to RENIS-FU, and 1368 (86%) gave a positive response, but 39 did not make their appointments and 5 subjects could not be examined because the antecubital vein could not be cannulated.
Accordingly, a total of 1324 (83%) patients were examined in RENIS-FU (Figure 1 ). In the present investigation, an additional 25 persons with diabetes (fasting glucose >= 126 mg/dL (7.0 mmol/l) and/or glycosylated hemoglobin (HbAR 1c R) >= 6.5%) at baseline were excluded.
The study was approved by the Norwegian Data Inspectorate and the Regional Ethics
Committee of Northern Norway (2012/122/REK nord). All subjects provided written informed consent.
Data Collection and Measurements
Both RENIS-T6 and RENIS-FU were conducted at the Clinical Research Unit at the University Hospital of Northern Norway with a standardized procedure and the same staff responsible for all measurements. Participants met between 8:00 and 10:00 a.m. after an overnight fast, including abstinence from tobacco.
Iohexol clearance
GFR was measured at baseline and follow-up using single-sample plasma clearance of iohexol. Participants were instructed to avoid large meals with meat and non-steroid antiinflammatory drugs during the 2 days prior to the investigation. A Teflon catheter was placed in an antecubital vein. Five milliliters of iohexol (Omnipaque, 300 mg/ml, Amersham Health, London, U.K.) was injected, and the syringe was weighed before and after injection. The venous catheter was flushed with 30 ml of isotonic saline. After a calculated time period based on each person's estimated GFR, the iohexol blood sample was drawn from the same catheter. The serum iohexol concentration was measured by high-performance liquid chromatography, as described by Nilsson-Ehle. 20 The analytical coefficient of variation during the study period was 3% in RENIS-T6 and 3.1% in RENIS-FU. To explore the possibility of a drift in the method between baseline and follow-up we reanalyzed iohexol and recalculated mGFR in a random sample of 105 serum samples frozen at -80°C at baseline.
There was a mean difference of 2.28 ml/min/1.73 m 2 between the original baseline measure and the repeated baseline measure taken from the thawed sample. An adjustment was made by adding this difference to the baseline measurements. mGFR was calculated as described by
Jacobsson. 21 Details regarding the iohexol clearance measurements are published elsewhere.
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Other measurements including albumin-creatinine ratio (ACR)
Serum creatinine analyses were performed using a standardized enzymatic assay, and cystatin C was measured by particle-enhanced turbidimetric immunoassay as previously described. 18 GFR was estimated from creatinine or cystatin C using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI). 15 Three samples of first-void morning spot urine were collected on separate days at baseline and at follow-up. Urinary albumin excretion and urinary creatinine were measured with commercial kits as described previously. 22 The albumin-creatinine ratio (ACR) in mg/mmol was calculated for each urine-specimen, and the mean ACR value was used in the analyses.
High normal ACR was defined as ACR > 10 mg/g (>1.13 mg/mmol) as suggested by the CKD Prognosis Consortium because this level has been associated with increased risks of CVD, CKD and mortality. Ambulatory blood pressure (aBP) recordings were started after the baseline iohexol clearance measurement (RENIS-T6) and continued for 24 hours; the method is described in a previous publication.
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Definition of prediabetes and hyperfiltration
We defined prediabetes according to fasting glucose (FG) and HbAR 1c R to capture both fasting hyperglycemia and part of non-fasting hyperglycemia, both of which may represent distinct pathophysiological abnormalities. Normoglycemia was defined as FG < 100 mg/dL (5.6 mmol/l) and HbAR 1C R < 5.7%.
Glomerular hyperfiltration was defined as an absolute GFR above the 90 th percentile after adjusting for gender, age, weight and height, as previously described. 12 25 Information regarding health status, medications, smoking status and physical exercise were obtained using a questionnaire. Smoking status was divided into current smokers and nonsmokers. Physically active participants were defined as those performing hard physical exercise for > 1 h/wk and/or light physical exercise for > 3 h/wk. 16 Obesity was defined as body mass index (BMI) ≥ 30 kg/m 2 .
Statistical analysis
Mean ( Predictors of annual change in absolute mGFR (ΔGFRa in ml/min/year) were analyzed with ΔGFRa as the dependent variable and using the same independent and adjusting variables as described above, including an adjustment for baseline mGFR in all of the models. In these analyses, we also adjusted for a change in body weight because body weight is correlated with absolute GFR (model 3). ΔGFRa was calculated by subtracting mGFR (ml/min) at baseline from mGFR (ml/min) at follow-up and dividing the difference by follow-up time in years.
To investigate a possible non-linear association between FG or HbAR 1c R and ΔGFRa or mGFR at follow-up, we used multiple fractional polynomial regression analyses, adjusting for the same variables as in model 3 of the linear regression analyses.
Multiple logistic regression models were used to determine the odds ratios for hyperfiltration, mGFR < 60 ml/min/1.73 m 2 or ACR > 10 mg/g (>1.1 mg/mmol) at follow-up associated with baseline FG, HbAR 1c R and prediabetes status, adjusted for the same variables described in the 3 models above. (In model 3 with ACR > 10 mg/g at follow-up as dependent variable we adjusted for baseline ACR instead of baseline mGFR). We tested for interactions between all independent variables and gender in all of the linear and logistic regression models.
Stata software version 13 (Stata Corp., College Station, Texas, USA) was used for statistical analysis. Statistical significance was set at P < 0.05.
RESULTS
Thirty-eight individuals had diabetes at follow-up (RENIS-FU); these persons were excluded.
Accordingly, 1261 non-diabetic persons with a GFR measurement at baseline and at follow- Comparisons of the baseline characteristic of those included in the follow-up study (N=1299)
and those lost to follow-up (N=295) are shown in Supplemental Table 1 . Age, night-time systolic aBP, BMI, insulin levels and triglyceride levels increased across the prediabetic groups while HDL-cholesterol levels, the proportion of females and the proportion performing physical exercise decreased across the groups. Baseline mGFR, but not eGFR from creatinine or cystatin C, was higher in the prediabetic groups. The distribution of mGFR and ACR (log-transformed) at baseline, and of change in mGFR and ACR (logtransformed) between baseline and follow-up is shown in Figure 2 .
The association between baseline glycemic status and mGFR at follow-up
Higher baseline FG and HbAR 1c R values and prediabetes according to either definition were associated with a higher mGFR at follow-up, adjusted for age, sex and use of ACE-i or ARB, systolic aBP, BMI, smoking status, fasting insulin levels, physical exercise and ACR (Table   2, Table 2 )
The mean annual change in mGFR (ΔGFRa in ml/min/year) was -1.0 (95% CI: -1.1 to -0.9) ml/min/year for persons without prediabetes and -0. Table   3 ).
There were no significant non-linear associations between FG or HbAR 1c R and ΔGFRa or mGFR at follow-up (Supplemental Figure 1a and 1b) .
Glycemic status and odds ratio for hyperfiltration, CKD and high normal ACR
The adjusted odds ratios for incident hyperfiltration and for CKD, defined as mGFR < 60 ml/min/1.73 m 2 at follow-up, are shown in Table 3 . Higher baseline FG and HbAR 1c R values and prediabetesR IEC R at baseline were associated with increased odds of hyperfiltration at follow-up (model 2, Table 3 ). HbAR 1c R and prediabetesR IEC R remained significant predictors of hyperfiltration after an additional adjustment for baseline hyperfiltration status (model 3).
High HbAR 1c R and prediabetesR ADA R were associated with reduced odds of having an mGFR < 60 ml/min/1.73 m 2 at follow-up in all models. R Eighty-eight persons had an ACR > 10 mg/g at follow-up. High baseline FG and prediabetesR IEC R, butR Rnot HbAR 1c R and prediabetesR ADA R, were associated with an increased odds for high normal ACR (Table 4) . Baseline FG remained a significant predictor of high normal ACR in all models, whereas prediabetesR IEC R was only borderline significant after adjusting for baseline ACR (model 3, Table 4 
DISCUSSION
In this cohort from a general middle-aged population without diabetes, we found that different measures of borderline hyperglycemia were predictors of higher mGFR and hyperfiltration after nearly 6 years follow up. FG and prediabetesR IEC Rw ere also risk factors for increased ACR.
To our knowledge, no prior study of the general population has assessed the longitudinal association between prediabetes and mGFR. In a study of Pima Indians, Nelson et al. found that mGFR (given as absolute GFR in ml/min) increased during 4 years follow up in 28
persons with an impaired glucose tolerance at baseline. 28 However, the mean baseline BMI in these individuals was 39 kg/m 2 , and the increase in mGFR was most prominent in the 12 persons who developed diabetes at follow-up. 28 Moreover, the results were not statistically significant when the change in mGFR was scaled by body surface area (ml/min/1.73 m 2 ). 29 Several previous population-based studies with 4-8 years of follow up reported that prediabetes did not predict CKD or decreased GFR when using eGFR after adjusting for cardiovascular risk factors. 6-9 Schottker et al. concluded that prediabetes is not a likely a cause for the development of kidney disease. 7 In contrast, we found that prediabetes predicted higher mGFR and hyperfiltration after almost six years of follow up. If hyperfiltration in prediabetes represents a maladaptive response to metabolic changes, as indicated by animal models and in studies of patients with diabetes, 13, 14, 30 the process of kidney damage is likely to start early in the course of chronic hyperglycemia. The current finding of an increased risk of developing elevated ACR for those with a higher baseline FG or prediabetesR IEC R after excluding persons with diabetes at baseline and follow-up supports this theory.
Hyperfiltration combined with hyperglycemia has been found to induce podocyte stress, podocyte injury, and cell apoptosis in animal models. 31 However, it remains unclear whether hyperfiltration itself is harmful and what the long-term consequences of hyperfiltration are in prediabetes. We did not find that prediabetes increased the odds ratio of having a mGFR < 60 ml/min/1.73 m 2 after 5.6 years. In contrast, HbAR 1c R and prediabetesR ADA R were associated with a reduced risk of mGFR < 60 ml/min/1.73 m 2 , most likely due to the hyperfiltration effect (Table 3) . A study of mGFR with a longer follow up time is needed to address whether hyperfiltration in prediabetes predicts overt CKD. Interestingly, a meta-analysis of diabetesrelated hyperfiltration studies that used mGFR, and also a recent prospective study of mGFR in 600 hypertensive patients with type 2 diabetes, found an increased hazard ratio of developing diabetes nephropathy in those with hyperfiltration at baseline. 13, 32 However, hyperfiltration did not predict diabetes nephropathy in studies that estimated the GFR by creatinine or cystatin C. 33, 34 Compared to persons with normoglycemia, our study found a significantly higher mGFR, but not a higher eGFRcre or eGFRcys, in persons with prediabetes at baseline. This difference may be due to the low precision of the equations used to estimate GFR in the normal range of GFR. Furthermore, it has recently been shown that risk factors such as fasting glucose, obesity and smoking, as well as non-traditional CVD risk factors, influence cystatin C-and creatinine-based eGFR after accounting for mGFR. [16] [17] [18] Accordingly, eGFR should not be used in studies of hyperfiltration and may also be inadequate in examining the association between glucose and early GFR decline.
Furthermore, the current finding of a longitudinal association between borderline hyperglycemia and increased mGFR or hyperfiltration has consequences for the use of GFR decline rate as an outcome in observational studies and clinical trials.
We found that high baseline FG and prediabetesR IEC R were associated with increased odds for high normal ACR. A few longitudinal investigations have reported the association between prediabetes or non-diabetic hyperglycemia and the risk of albuminuria; the results are conflicting. 9, 10, 35 Most of these studies did not adjust for other cardiovascular risk factors, but in two population-based studies in persons without diabetes, increased FG in men and HbAR 1c R in both genders were found to be independent predictors of increased urinary albumin excretion. 22, 36 However, neither of these studies excluded persons with diabetes at follow-up.
Because elevated ACR may be a result of hypertension and early nephropathy, we adjusted for baseline ambulatory BP, use of antihypertensive medication and change in antihypertensive medication during follow-up, and obtained similar results. We also adjusted for fasting insulin levels because reduced insulin sensitivity has been associated with greater risk of albuminuria. 37 Our results are noteworthy because ACR > 10 mg/g has been found to predict CVD, CKD and death in general-population cohorts. 23, 24 Importantly, potential interventions like diet and physical activity promotion programs in prediabetes have been shown to reduces glucose levels. 38 Furthermore, physical exercise have been shown to reduce the odds ratio of hyperfiltration and to modify the effect of fasting glucose on GFR. 39 In addition, new treatment options in hyperglycemia like the Sodium/Glucose Cotransporter 2 (SGLT2) inhibitors may prevent hyperfiltration independently of the glucose lowering effect. 40 However, a possible renoprotective effect of physical exercise and SGLT2 inhibition needs to been confirmed.
Our study has some limitations, including the following: only middle-aged Caucasians participated, limiting generalizability to other groups; furthermore, we did not perform a glucose tolerance test to assess non-fasting hyperglycemia. However, we combined fasting glucose and HbAR 1c R and used accepted definitions of prediabetes. 26, 27 There is no consensus on how to define glomerular hyperfiltration in population studies. Hyperfiltration at a whole kidney level is likely to reflect hyperfiltration at the glomerular level, but is also influenced by the number of nephrons. Since nephron numbers varies between individuals and by sex and age, we used an adjusted definition of hyperfiltration as reported in detail previously.
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A major strength of this study is that GFR was measured by iohexol clearance at baseline and follow-up in a large cohort from the general population. To our knowledge, RENIS is the only longitudinal study measuring GFR in the general population. FG and HbAR 1c R were measured twice, and we excluded those persons who developed diabetes at follow-up. Urine was collected on three separate days both at baseline and at follow-up, and albumin and creatinine were assessed in unfrozen specimens. Finally, we were able to control for several possible confounders, including ambulatory BP at baseline and changes in antihypertensive medication during follow-up.
In conclusion, we found that prediabetes was an independent risk factor for hyperfiltration and increased ACR during 5.6 years follow up in a representative cohort of the general population. Our findings suggest an independent role of prediabetes in CKD development and may in part explain the negative results of previous longitudinal studies of prediabetes that defined CKD based on eGFR only. Studies with longer follow up times, preferably with measured GFR and/or with albuminuria as outcomes, are needed to establish whether nondiabetic hyperglycemia is an independent predictor of CKD. If so, prediabetes might be a target for early treatment to prevent the increasing burden of CKD in diabetes. important intellectual content during manuscript drafting or revision and accepts accountability for the overall work by ensuring that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved. TM and BOE take responsibility that this study has been reported honestly, accurately, and transparently;
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